Research Education Component
Research Education Component
批准号:
10264194
负责人:
ROBERTA EILEEN BRINTON
金额:
$19.07万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-09-05 至 2026-06-30
关键词:
Academic TrainingAddressAdvanced DevelopmentAgingAlzheimer disease preventionAlzheimer&aposs DiseaseAlzheimer&aposs disease related dementiaArizonaBiological MarkersClinicalCollaborationsCommunitiesComplementDataData ScienceDiagnosisDiseaseEducation and OutreachEthicsFosteringFutureGoalsHispanic-serving InstitutionHispanicsHuman ResourcesLeadershipMentorshipMinorityModelingNational Institute of Neurological Disorders and StrokeNative AmericansNative-BornNeurodegenerative DisordersOccupational activity of managing financesOutcomePersonnel ManagementPersonsPopulation HeterogeneityPositioning AttributePostdoctoral FellowRecommendationReproducibilityResearchResearch PersonnelResourcesScienceTRADD geneTraining ProgramsTranslational ResearchUnderrepresented PopulationsUnited States National Institutes of Healthblood-based biomarkercareercareer developmentclinically relevantcohortcollegeeducation researcheducational atmosphereexperiencefaculty researchfight againstfightinginnovationmultidisciplinarynext generationpersonalized strategiespre-doctoralpreclinical studypreventprogramsrate of changerecruitscience educationskill acquisitionskillssuccesssymposiumundergraduate researchundergraduate student
中文摘要
点击翻译按钮获取中文摘要
英文摘要
SUMMARY/ABSTRACT - RESEARCH EDUCATION COMPONENT (REC)
The Arizona ADRC REC training program addresses goals and objectives of the National Alzheimer's Project
Act (NACA) "To prevent and effectively treat Alzheimer's Disease and Related Dementias (AD/ADRD) by 2025.”
It is aligned with NIH AD and ADRD Research Summit recommendations, the ADRC's overarching theme (blood-
based biomarkers (“BBBs) in the diagnosis, preclinical study and prevention of AD/ADRD, its aggressively
collaborative model, and our commitment to help develop the next generation of AD/ADRD researchers,
including those from diverse backgrounds. We propose a personalized strategy to engage and advance junior
faculty and research associates to conduct innovative integrative AD/ADRD research that is clinically relevant,
translationally valid, scientifically reproducible and includes under-represented groups. To address gaps in
academic training, the AZ ADRC REC will advance the development of skills necessary to achieve success in
21st century team science, leadership, personnel and financial management and collaborative ethical research;
further develop and apply their expertise and skills in the fight against AD and ADRD; and capitalize on our
programs and Resource Center for Minority Aging Research (RCMAR) partnerships to advance research careers
and studies involving persons from Hispanic, Native American and other under-represented communities.
To build the pipeline of future AD/ ADRD researchers, we propose an experience dependent mentorship
strategy in which the AZ ADRC REC complements NIH / NIA training programs for postdoctoral, predoctoral and
undergraduate research fellows and spans ethnic, cultural and professional diversity. Strategies to achieve these
goals include: Specific Aim 1: Personalized AD/ADRD Research Career Plan for 21st Century Team Science;
Specific Aim 2: Leadership and Ethics at the Rate of Change in the 21st Century and Specific Aim 3: Building
the Alzheimer's Research Career Pipeline for the Future. Outcomes of these endeavors will advance the overall
ADRC goals articulated in the NIH/NIA Alzheimer's Disease Research Centers RFA-AG-20-004 including:
“Create a dynamic educational environment that supports disruptive and transformative research.
Accelerate translational research across the spectrum of disease.
Demonstrate scientifically productive interactions across NIH and other Federal Center programs.
Provide a mechanism for data science education relevant to neurodegenerative disease research.
Facilitate career development to increase diversity of leadership positions within the Center.
Education and outreach activities aligned with Clinical Core for recruitment of diverse populations.”
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Translational Research in Alzheimer's Disease and related Dementias (TRADD)
-
批准号:10709167
-
项目类别:
-
资助金额:$29.45万
-
财政年份:2023
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
Novel Intranasal Formulations of Allopregnanolone, a Regenerative Therapeutic for Alzheimer's Disease
-
批准号:10698555
-
项目类别:
-
资助金额:$50.58万
-
财政年份:2023
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
PhytoSERM Efficacy to Prevent Menopause Associated Decline in Brain Metabolism and Cognition: A Double-Blind, Randomized, Placebo-Controlled Phase 2 Clinical Trial
-
批准号:10560591
-
项目类别:
-
资助金额:$154.45万
-
财政年份:2022
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
PhytoSERM for Menopausal Hot Flashes and Sustained Brain Health
-
批准号:10547639
-
项目类别:
-
资助金额:$133.74万
-
财政年份:2022
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
PhytoSERM Efficacy to Prevent Menopause Associated Decline in Brain Metabolism and Cognition: A Double-Blind, Randomized, Placebo-Controlled Phase 2 Clinical Trial
-
批准号:10344556
-
项目类别:
-
资助金额:$212.12万
-
财政年份:2022
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
PhytoSERM for Menopausal Hot Flashes and Sustained Brain Health
-
批准号:10707107
-
项目类别:
-
资助金额:$119.93万
-
财政年份:2022
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
Regulatory and Human Study Operations (RHSO) Core C
-
批准号:10689308
-
项目类别:
-
资助金额:$27.95万
-
财政年份:2021
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
Regulatory and Human Study Operations (RHSO) Core C
-
批准号:10491851
-
项目类别:
-
资助金额:$27.95万
-
财政年份:2021
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
Regulatory and Human Study Operations (RHSO) Core C
-
批准号:10270190
-
项目类别:
-
资助金额:$28.71万
-
财政年份:2021
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
Undergraduate Readying for Burgeoning Research for American Indian Neuroscientists
-
批准号:10199069
-
项目类别:
-
资助金额:$23.88万
-
财政年份:2019
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
Allopregnanolone as Regenerative Therapeutic for Alzheimer's: Phase 2 Clinical Trial
-
批准号:9991710
-
项目类别:
-
资助金额:$737.08万
-
财政年份:2019
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
Novel formulations of Allopregnanolone to treat Alzheimer's Disease
-
批准号:9906039
-
项目类别:
-
资助金额:$44.99万
-
财政年份:2019
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
Allopregnanolone as Regenerative Therapeutic for Alzheimer's: Phase 2 Clinical Trial
-
批准号:10411886
-
项目类别:
-
资助金额:$755.24万
-
财政年份:2019
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
Allopregnanolone as Regenerative Therapeutic for Alzheimer's: Phase 2 Clinical Trial
-
批准号:10674824
-
项目类别:
-
资助金额:$728.0万
-
财政年份:2019
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
Undergraduate Readying for Burgeoning Research for American Indian Neuroscientists
-
批准号:9793963
-
项目类别:
-
资助金额:$25.48万
-
财政年份:2019
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
Undergraduate Readying for Burgeoning Research for American Indian Neuroscientists
-
批准号:10437663
-
项目类别:
-
资助金额:$23.65万
-
财政年份:2019
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
Undergraduate Readying for Burgeoning Research for American Indian Neuroscientists
-
批准号:10645075
-
项目类别:
-
资助金额:$23.65万
-
财政年份:2019
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
Sex Differences in the Molecular Determinants of Alzheimer's Disease Risk: Prodromal Endophenotype
-
批准号:9770740
-
项目类别:
-
资助金额:$114.13万
-
财政年份:2018
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
Translational Research in AD and related Dementias (TRADD)
-
批准号:10475657
-
项目类别:
-
资助金额:$20.87万
-
财政年份:2018
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
Translational Research in AD and related Dementias (TRADD)
-
批准号:10219144
-
项目类别:
-
资助金额:$30.36万
-
财政年份:2018
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
海外基金